Daytime Sleepiness in Parkinson's Disease: Perception, Influence of Drugs, and Mood Disorder. (22nd January 2014)

• Record Type: Journal Article
• Authors: Ataide, M.; Franco, C. M. R.; Lins, O. G.
• Other Names: Garcia-Borreguero Diego Academic Editor.
• Is Part Of: Sleep disorders. Volume 2014(2014)
• Publication Date: 2014-01-22
• Subjects: Sleep disorders -- Periodicals; 616.8498005
• DOI: 10.1155/2014/939713
• Languages: English
• ISSNs: 2090-3545

Abstract

Abstract : Parkinson's disease (PD) is associated with sleep complaints as excessive daytime sleepiness (EDS) and several factors have been implicated in the genesis of these complaints. Objective . To correlate the subjective perception of EDS with variables as the severity of the motor symptoms, medications, and the presence of depressive symptoms. Materials and Methods . A cross-sectional study, using specific scales as Epworth sleepiness scale (ESS), Beck depression inventory (iBeck) and Hoehn and Yahr (HY), in 42 patients with PD. Results . The patients had a mean age of61.2 ± 11.3 years and mean disease duration of4.96 ± 3.3 years. The mean ESS was7.5 ± 4.7 and 28.6% of patients reached a score of abnormally high value (> 10 ). There was no association with gender, disease duration, and dopamine agonists. Patients with EDS used larger amounts of levodopa (366.7 ± 228.0 versus460.4 ± 332.25 mg, P = 0.038 ), but those who had an iBeck> 20 reached lower values of ESS than the others (5.9 ± 4.1 versus9.3 ± 4.8, P = 0.03 ). Conclusions . EDS was common in PD patients, being related to levodopa intake. Presence of depressed mood may influence the final results of self-assessment scales for sleep disorders.